{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:44:04Z","timestamp":1773294244719,"version":"3.50.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T00:00:00Z","timestamp":1464134400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s40263-016-0346-3","type":"journal-article","created":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T11:17:20Z","timestamp":1464175040000},"page":"541-558","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Relationships Between Functional Outcomes and Symptomatic Improvement in Atomoxetine-Treated Adult Patients with Attention-Deficit\/Hyperactivity Disorder: Post Hoc Analysis of an Integrated Database"],"prefix":"10.1007","volume":"30","author":[{"given":"Katrien","family":"De Bruyckere","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Bushe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Bartel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lovisa","family":"Berggren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelis C.","family":"Kan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf W.","family":"Dittmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,25]]},"reference":[{"issue":"2","key":"346_CR1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jpsychires.2010.06.009","volume":"45","author":"J Biederman","year":"2011","unstructured":"Biederman J, Petty CR, Clarke A, et al. Predictors of persistent ADHD: an 11-year follow-up study. J Psychiatr Res. 2011;45(2):150\u20135.","journal-title":"J Psychiatr Res."},{"issue":"2","key":"346_CR2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1017\/S003329170500471X","volume":"36","author":"SV Faraone","year":"2006","unstructured":"Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. 2006;36(2):159\u201365.","journal-title":"Psychol Med."},{"key":"346_CR3","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1192\/bjp.bp.106.034389","volume":"190","author":"J Fayyad","year":"2007","unstructured":"Fayyad J, De Graaf R, Kessler R, et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry. 2007;190:402\u20139.","journal-title":"Br J Psychiatry."},{"issue":"4","key":"346_CR4","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1176\/ajp.2006.163.4.716","volume":"163","author":"RC Kessler","year":"2006","unstructured":"Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716\u201323.","journal-title":"Am J Psychiatry."},{"issue":"3","key":"346_CR5","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1192\/bjp.bp.107.048827","volume":"194","author":"V Simon","year":"2009","unstructured":"Simon V, Czobor P, B\u00e1lint S, et al. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry. 2009;194(3):204\u201311.","journal-title":"Br J Psychiatry."},{"issue":"2","key":"346_CR6","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/01.chi.0000189134.97436.e2","volume":"45","author":"RA Barkley","year":"2006","unstructured":"Barkley RA, Fischer M, Smallish L, Fletcher K. Young adult outcome of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry. 2006;45(2):192\u2013202.","journal-title":"J Am Acad Child Adolesc Psychiatry."},{"issue":"3","key":"346_CR7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/arclin\/acq014","volume":"25","author":"RA Barkley","year":"2010","unstructured":"Barkley RA, Murphy KR. Impairment in occupational functioning and adult ADHD: the predictive utility of executive function (EF) ratings versus EF tests. Arch Clin Neuropsychol. 2010;25(3):157\u201373.","journal-title":"Arch Clin Neuropsychol."},{"issue":"4","key":"346_CR8","doi-asserted-by":"crossref","first-page":"524","DOI":"10.4088\/JCP.v67n0403","volume":"67","author":"J Biederman","year":"2006","unstructured":"Biederman J, Faraone SV, Spencer TJ, et al. Functional impairments in adults with self-reports of diagnosed ADHD: A controlled study of 1001 adults in the community. J Clin Psychiatry. 2006;67(4):524\u201340.","journal-title":"J Clin Psychiatry."},{"issue":"2","key":"346_CR9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12402-014-0126-1","volume":"6","author":"M Fredriksen","year":"2014","unstructured":"Fredriksen M, Dahl AA, Martinsen EW, et al. Childhood and persistent ADHD symptoms associated with educational failure and long-term occupational disability in adult ADHD. Atten Defic Hyperact Disord. 2014;6(2):87\u201399.","journal-title":"Atten Defic Hyperact Disord."},{"issue":"12","key":"346_CR10","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/archgenpsychiatry.2012.271","volume":"69","author":"RG Klein","year":"2012","unstructured":"Klein RG, Mannuzza S, Olazagasti MA, et al. Clinical and functional outcome of childhood ADHD 33\u00a0years later. Arch Gen Psychiatry. 2012;69(12):1295\u2013303.","journal-title":"Arch Gen Psychiatry."},{"key":"346_CR11","doi-asserted-by":"publisher","unstructured":"Miranda A, Mercader J, Fern\u00e1ndez MI, Colomer C. Reading performance of young adults with ADHD diagnosed in childhood: relations with executive functioning. J Atten Disord. 2013. doi: 10.1177\/1087054713507977 .","DOI":"10.1177\/1087054713507977"},{"key":"346_CR12","unstructured":"da Silva MA, Chaim TM, Cavalett M, et al. Health-related quality of life in adults with attention-deficit and hyperactivity disorder. http:\/\/www.dx.doi.org\/10.5935\/MedicalExpress.2014.01.10 ."},{"issue":"5\u20136","key":"346_CR13","first-page":"10","volume":"9","author":"R Agarwal","year":"2012","unstructured":"Agarwal R, Goldenberg M, Perry R, IsHak WW. The quality of life of adults with attention deficit hyperactivity disorder: a systematic review. Innov Clin Neurosci. 2012;9(5\u20136):10\u201321.","journal-title":"Innov Clin Neurosci."},{"issue":"9983","key":"346_CR14","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/S0140-6736(14)61684-6","volume":"385","author":"S Dalsgaard","year":"2015","unstructured":"Dalsgaard S, \u00d8stergaard SD, Leckman JF, et al. Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study. Lancet. 2015;385(9983):2190\u20136.","journal-title":"Lancet."},{"issue":"9","key":"346_CR15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1741-7015-9-72","volume":"10","author":"KM Antshel","year":"2011","unstructured":"Antshel KM, Hargrave TM, Simonescu M, et al. Advances in understanding and treating ADHD. BMC Med. 2011;10(9):72.","journal-title":"BMC Med."},{"issue":"2","key":"346_CR16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1469-7610.2004.00214.x","volume":"45","author":"RA Barkley","year":"2004","unstructured":"Barkley RA, Fischer M, Smallish L, Fletcher K. Young adult follow-up of hyperactive children: antisocial activities and drug use. J Child Psychol Psychiatry. 2004;45(2):195\u2013211.","journal-title":"J Child Psychol Psychiatry."},{"issue":"3","key":"346_CR17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jamapsychiatry.2013.4174","volume":"71","author":"Z Chang","year":"2014","unstructured":"Chang Z, Lichtenstein P, D\u2019Onofrio BM, et al. Serious transport accidents in adults with attention-deficit\/hyperactivity disorder and the effect of medication: a population-based study. JAMA Psychiatry. 2014;71(3):319\u201325.","journal-title":"JAMA Psychiatry."},{"issue":"1","key":"346_CR18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.aap.2006.06.008","volume":"39","author":"M Fischer","year":"2007","unstructured":"Fischer M, Barkley RA, Smallish L, Fletcher K. Hyperactive children as young adults: driving abilities, safe driving behavior, and adverse driving outcomes. Accid Anal Prev. 2007;39(1):94\u2013105.","journal-title":"Accid Anal Prev."},{"issue":"3","key":"346_CR19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.psychres.2007.11.003","volume":"160","author":"S Mannuzza","year":"2008","unstructured":"Mannuzza S, Klein RG, Moulton JL 3rd. Lifetime criminality among boys with attention deficit hyperactivity disorder: a prospective follow-up study into adulthood using official arrest records. Psychiatry Res. 2008;160(3):237\u201346.","journal-title":"Psychiatry Res."},{"issue":"7","key":"346_CR20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00406-007-0712-8","volume":"257","author":"E Sobanski","year":"2007","unstructured":"Sobanski E, Br\u00fcggemann D, Alm B, et al. Psychiatric comorbidity and functional impairment in a clinically referred sample of adults with attention-deficit\/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci. 2007;257(7):371\u20137.","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"issue":"Suppl 12","key":"346_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1092852900026158","volume":"12","author":"JH Newcorn","year":"2007","unstructured":"Newcorn JH, Weiss M, Stein MA. The complexity of ADHD: diagnosis and treatment of the adult patient with comorbidities. CNS Spectr. 2007;12(Suppl 12):1\u201314 (quiz 15\u20136).","journal-title":"CNS Spectr."},{"key":"346_CR22","doi-asserted-by":"publisher","unstructured":"Ginsberg Y, Quintero J, Anand E, et al. Underdiagnosis of attention-deficit\/hyperactivity disorder in adult patients: a review of the literature. Prim Care Companion CNS Disord. 2014;16(3). doi: 10.4088\/PCC.13r01600 .","DOI":"10.4088\/PCC.13r01600"},{"key":"346_CR23","first-page":"1","volume":"6","author":"C Bushe","year":"2015","unstructured":"Bushe C, Wilson B, Televantou F, et al. Understanding the treatment of attention deficit hyperactivity disorder in newly diagnosed adult patients in general practice: a UK database study. Pragmat Obs Res. 2015;6:1\u201312.","journal-title":"Pragmat Obs Res."},{"issue":"5","key":"346_CR24","first-page":"196","volume":"126","author":"DB Clemow","year":"2014","unstructured":"Clemow DB. Suboptimal dosing of Strattera (atomoxetine) for ADHD patients. Postgrad Med. 2014;126(5):196\u20138.","journal-title":"Postgrad Med."},{"issue":"10","key":"346_CR25","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2165\/11537450-000000000-00000","volume":"24","author":"D Coghill","year":"2010","unstructured":"Coghill D. The impact of medications on quality of life in attention-deficit hyperactivity disorder: a systematic review. CNS Drugs. 2010;24(10):843\u201366.","journal-title":"CNS Drugs."},{"issue":"6","key":"346_CR26","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1177\/1087054707308490","volume":"11","author":"LA Adler","year":"2008","unstructured":"Adler LA, Spencer TJ, Levine LR, et al. Functional outcomes in the treatment of adults with ADHD. J Atten Disord. 2008;11(6):720\u20137.","journal-title":"J Atten Disord."},{"issue":"3","key":"346_CR27","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/da.20549","volume":"26","author":"LA Adler","year":"2009","unstructured":"Adler LA, Liebowitz M, Kronenberger W, et al. Atomoxetine treatment in adults with attention-deficit\/hyperactivity disorder and comorbid social anxiety disorder. Depress Anxiety. 2009;26(3):212\u201321.","journal-title":"Depress Anxiety."},{"issue":"1","key":"346_CR28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/JCP.0b013e31827d8a23","volume":"33","author":"TM Durell","year":"2013","unstructured":"Durell TM, Adler LA, Williams DW, et al. Atomoxetine treatment of attention-deficit\/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlled clinical trial. J Clin Psychopharmacol. 2013;33(1):45\u201354.","journal-title":"J Clin Psychopharmacol"},{"key":"346_CR29","doi-asserted-by":"publisher","unstructured":"Goto T, Hirata Y, Takita Y, et al. Efficacy and safety of atomoxetine hydrochloride in Asian adults with ADHD: a multinational 10-week randomized double-blind placebo-controlled Asian study. J Atten Disord. 2013. doi: 10.1177\/1087054713510352 .","DOI":"10.1177\/1087054713510352"},{"issue":"1","key":"346_CR30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/JCP.0b013e318192e4a0","volume":"29","author":"LA Adler","year":"2009","unstructured":"Adler LA, Spencer T, Brown TE, et al. Once-daily atomoxetine for adult attention-deficit\/hyperactivity disorder: a 6-month, double-blind trial. J Clin Psychopharmacol. 2009;29(1):44\u201350.","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"346_CR31","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0006-3223(02)01671-2","volume":"53","author":"D Michelson","year":"2003","unstructured":"Michelson D, Adler L, Spencer T, et al. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry. 2003;53(2):112\u201320.","journal-title":"Biol Psychiatry."},{"issue":"6","key":"346_CR32","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1177\/1087054707308503","volume":"11","author":"LA Adler","year":"2008","unstructured":"Adler LA, Faraone SV, Spencer TJ, et al. The reliability and validity of self- and investigator ratings of ADHD in adults. J Atten Disord. 2008;11(6):711\u20139.","journal-title":"J Atten Disord."},{"issue":"4","key":"346_CR33","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/JCP.0000000000000138","volume":"34","author":"LA Adler","year":"2014","unstructured":"Adler LA, Tanaka Y, Williams D, et al. Executive function in adults with attention-deficit\/hyperactivity disorder during treatment with atomoxetine in a randomized, placebo-controlled, withdrawal study. J Clin Psychopharmacol. 2014;34(4):461\u20136.","journal-title":"J Clin Psychopharmacol."},{"issue":"8","key":"346_CR34","doi-asserted-by":"crossref","first-page":"e104175","DOI":"10.1371\/journal.pone.0104175","volume":"9","author":"LA Adler","year":"2014","unstructured":"Adler LA, Clemow DB, Williams DW, Durell TM. Atomoxetine effects on executive function as measured by the BRIEF-A in young adults with ADHD: a randomized, double-blind, placebo-controlled study. PLoS One. 2014;9(8):e104175.","journal-title":"PLoS One."},{"issue":"21","key":"346_CR35","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa1203241","volume":"367","author":"P Lichtenstein","year":"2012","unstructured":"Lichtenstein P, Halldner L, Zetterqvist J, et al. Medication for attention deficit-hyperactivity disorder and criminality. N Engl J Med. 2012;367(21):2006\u201314.","journal-title":"N Engl J Med."},{"issue":"3","key":"346_CR36","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1177\/1087054706292122","volume":"10","author":"RA Barkley","year":"2007","unstructured":"Barkley RA, Anderson DL, Kruesi M. A pilot study of atomoxetine on driving performance in adults with ADHD. J Atten Disord. 2007;10(3):306\u201313.","journal-title":"J Atten Disord."},{"issue":"4","key":"346_CR37","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1177\/1087054708322986","volume":"12","author":"GG Kay","year":"2009","unstructured":"Kay GG, Michaels MA, Pakull B. Simulated driving changes in young adults with ADHD receiving mixed amphetamine salts extended release and atomoxetine. J Atten Disord. 2009;12(4):316\u201329.","journal-title":"J Atten Disord."},{"issue":"6","key":"346_CR38","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.eurpsy.2012.08.001","volume":"28","author":"E Sobanski","year":"2013","unstructured":"Sobanski E, Sabljic D, Alm B, et al. Driving performance in adults with ADHD: results from a randomized, waiting list controlled trial with atomoxetine. Eur Psychiatry. 2013;28(6):379\u201385.","journal-title":"Eur Psychiatry."},{"issue":"2","key":"346_CR39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1524-4733.1999.02210.x","volume":"2","author":"NK Leidy","year":"1999","unstructured":"Leidy NK, Revicki DA, Genest\u00e9 B. Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value Health. 1999;2(2):113\u201327.","journal-title":"Value Health."},{"issue":"1\u20132","key":"346_CR40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.drugalcdep.2008.02.009","volume":"96","author":"TE Wilens","year":"2008","unstructured":"Wilens TE, Adler LA, Weiss MD, et al. Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug Alcohol Depend. 2008;96(1\u20132):145\u201354.","journal-title":"Drug Alcohol Depend."},{"issue":"9","key":"346_CR41","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1177\/0269881114542453","volume":"28","author":"P Asherson","year":"2014","unstructured":"Asherson P, Bushe C, Saylor K, et al. Efficacy of atomoxetine in adults with attention deficit hyperactivity disorder: an integrated analysis of the complete database of multicenter placebo-controlled trials. J Psychopharmacol. 2014;28(9):837\u201346.","journal-title":"J Psychopharmacol."},{"key":"346_CR42","volume-title":"Conners\u2019 Adult ADHD Rating Scales (CAARS)","author":"CK Conners","year":"1999","unstructured":"Conners CK, Erhardt D, Sparrow E. Conners\u2019 Adult ADHD Rating Scales (CAARS). North Tonawanda: Multi-Health Systems Inc; 1999."},{"issue":"1","key":"346_CR43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11136-005-8325-z","volume":"15","author":"M Brod","year":"2006","unstructured":"Brod M, Johnston J, Able S, Swindle R. Validation of the adult attention-deficit\/hyperactivity disorder quality-of-life Scale (AAQoL): a disease-specific quality-of-life measure. Qual Life Res. 2006;15(1):117\u201329.","journal-title":"Qual Life Res."},{"issue":"2","key":"346_CR44","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12402-014-0160-z","volume":"7","author":"M Brod","year":"2015","unstructured":"Brod M, Adler LA, Lipsius S, et al. Validation of the adult attention-deficit\/hyperactivity disorder quality-of-life scale in European patients: comparison with patients from the USA. Atten Defic Hyperact Disord. 2015;7(2):141\u201350.","journal-title":"Atten Defic Hyperact Disord."},{"issue":"10","key":"346_CR45","first-page":"887","volume":"19","author":"T Coles","year":"2014","unstructured":"Coles T, Coon C, DeMuro C, et al. Psychometric evaluation of the Sheehan Disability Scale in adult patients with attention-deficit\/hyperactivity disorder. Neuropsychiatr Dis Treat. 2014;19(10):887\u201395.","journal-title":"Neuropsychiatr Dis Treat."},{"issue":"6","key":"346_CR46","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473\u201383.","journal-title":"Med Care."},{"issue":"5","key":"346_CR47","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/arclin\/act031","volume":"28","author":"RM Roth","year":"2013","unstructured":"Roth RM, Lance CE, Isquith PK, Fischer AS, Giancola PR. Confirmatory factor analysis of the Behavior Rating Inventory of Executive Function-Adult version in healthy adults and application to attention-deficit\/hyperactivity disorder. Arch Clin Neuropsychol. 2013;28(5):425\u201334.","journal-title":"Arch Clin Neuropsychol."},{"key":"346_CR48","volume-title":"Conners\u2019 adult ADHD diagnostic interview for DSM-IV (CAADID)","author":"J Epstein","year":"1999","unstructured":"Epstein J, Johnson D, Conners CK. Conners\u2019 adult ADHD diagnostic interview for DSM-IV (CAADID). New York: Multi Health Systems Inc; 1999."},{"issue":"2","key":"346_CR49","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.psc.2003.12.003","volume":"27","author":"L Adler","year":"2004","unstructured":"Adler L, Cohen J. Diagnosis and evaluation of adults with attention-deficit\/hyperactivity disorder. Psychiatr Clin North Am. 2004;27(2):187\u2013201.","journal-title":"Psychiatr Clin North Am."},{"key":"346_CR50","unstructured":"MHRA public assessment report. Atomoxetine hydrochloride. http:\/\/webarchive.nationalarchives.gov.uk\/20141205150130\/ , http:\/\/www.mhra.gov.uk\/home\/groups\/pl-a\/documents\/websiteresources\/con020684.pdf . Accessed 15 July 2015."},{"key":"346_CR51","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s11136-007-9254-9","volume":"16","author":"LS Matza","year":"2007","unstructured":"Matza LS, Johnston JA, Faries DE, et al. Responsiveness of adult attentiondeficit\/hyperactivity disorder quality of life scale (AAQoL). Qual Life Res. 2007;16:1511\u201320.","journal-title":"Qual Life Res."},{"issue":"3","key":"346_CR52","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1590\/S0101-60832011000300002","volume":"38","author":"P Mattos","year":"2011","unstructured":"Mattos P, Segenreich D, Macedo Dias G, et al. Construct reliability and validity of the Portuguese version of the Adult ADHD Quality of Life Questionnaire (AAQoL). Rev Psiq Cl\u00edn. 2011;38(3):91\u20136.","journal-title":"Rev Psiq Cl\u00edn."},{"key":"346_CR53","unstructured":"Atomoxetine to treat Asian adult patients with attention-deficit\/hyperactivity disorder. https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT00962104 . Accessed 29 Sept 2015."},{"key":"346_CR54","unstructured":"Strattera (LY139603). http:\/\/www.lillytrials.com\/results\/Strattera.pdf . Accessed 29 Sept 2015."},{"issue":"6","key":"346_CR55","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/01.jcp.0000239797.21826.70","volume":"26","author":"LA Adler","year":"2006","unstructured":"Adler LA, Sutton VK, Moore RJ, et al. Quality of life assessment in adult patients with attention-deficit\/hyperactivity disorder treated with atomoxetine. J Clin Psychopharmacol. 2006;26(6):648\u201352.","journal-title":"J Clin Psychopharmacol."},{"issue":"3","key":"346_CR56","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/appy.12119","volume":"6","author":"Y Hirata","year":"2014","unstructured":"Hirata Y, Goto T, Takita Y, et al. Long-term safety and tolerability of atomoxetine in Japanese adults with attention deficit hyperactivity disorder. Asia Pac Psychiatry. 2014;6(3):292\u2013301.","journal-title":"Asia Pac Psychiatry."},{"issue":"3","key":"346_CR57","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s12402-011-0054-2","volume":"3","author":"BK Marchant","year":"2011","unstructured":"Marchant BK, Reimherr FW, Halls C, et al. Long-term open-label response to atomoxetine in adult ADHD: influence of sex, emotional dysregulation, and double-blind response to atomoxetine. Atten Defic Hyperact Disord. 2011;3(3):237\u201344.","journal-title":"Atten Defic Hyperact Disord."},{"issue":"2","key":"346_CR58","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/WNF.0b013e31820c00eb","volume":"34","author":"JL Young","year":"2011","unstructured":"Young JL, Sarkis E, Qiao M, Wietecha L. Once-daily treatment with atomoxetine in adults with attention-deficit\/hyperactivity disorder: a 24-week, randomized, double-blind, placebo-controlled trial. Clin Neuropharmacol. 2011;34(2):51\u201360.","journal-title":"Clin Neuropharmacol."},{"issue":"3","key":"346_CR59","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/1087054708316250","volume":"12","author":"LA Adler","year":"2008","unstructured":"Adler LA, Spencer TJ, Williams DW, et al. Long-term, open-label safety and efficacy of atomoxetine in adults with ADHD: final report of a 4-year study. J Atten Disord. 2008;12(3):248\u201353.","journal-title":"J Atten Disord."},{"issue":"3","key":"346_CR60","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4088\/JCP.v66n0304","volume":"66","author":"LA Adler","year":"2005","unstructured":"Adler LA, Spencer TJ, Milton DR, et al. Long-term, open-label study of the safety and efficacy of atomoxetine in adults with attention-deficit\/hyperactivity disorder: an interim analysis. J Clin Psychiatry. 2005;66(3):294\u20139.","journal-title":"J Clin Psychiatry."},{"issue":"4","key":"346_CR61","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3109\/15622975.2011.571283","volume":"14","author":"M R\u00f6sler","year":"2013","unstructured":"R\u00f6sler M, Ginsberg Y, Arngrim T, et al. Correlation of symptomatic improvements with functional improvements and patient-reported outcomes in adults with attention-deficit\/hyperactivity disorder treated with OROS methylphenidate. World J Biol Psychiatry. 2013;14(4):282\u201390.","journal-title":"World J Biol Psychiatry."},{"issue":"9","key":"346_CR62","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s40261-014-0213-2","volume":"34","author":"M Huss","year":"2014","unstructured":"Huss M, Ginsberg Y, Arngrim T, et al. Open-label dose optimization of methylphenidate modified release long acting (MPH-LA): a post hoc analysis of real-life titration from a 40-week randomized trial. Clin Drug Investig. 2014;34(9):639\u201349.","journal-title":"Clin Drug Investig."},{"issue":"4","key":"346_CR63","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3109\/15622975.2011.600333","volume":"14","author":"M Casas","year":"2013","unstructured":"Casas M, R\u00f6sler M, Sandra Kooij JJ, et al. Efficacy and safety of prolonged-release OROS methylphenidate in adults with attention deficit\/hyperactivity disorder: a 13-week, randomized, double-blind, placebo-controlled, fixed-dose study. World J Biol Psychiatry. 2013;14(4):268\u201381.","journal-title":"World J Biol Psychiatry."},{"issue":"2","key":"346_CR64","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/JCP.0b013e3181d21763","volume":"30","author":"R Escobar","year":"2010","unstructured":"Escobar R, Schacht A, Wehmeier PM, Wagner T. Quality of life and attention-deficit\/hyperactivity disorder core symptoms: a pooled analysis of 5 non-US atomoxetine clinical trials. J Clin Psychopharmacol. 2010;30(2):145\u201351.","journal-title":"J Clin Psychopharmacol."},{"issue":"3","key":"346_CR65","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00004703-200406000-00005","volume":"25","author":"LS Matza","year":"2004","unstructured":"Matza LS, Rentz AM, Secnik K, et al. The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder. J Dev Behav Pediatr. 2004;25(3):166\u201374.","journal-title":"J Dev Behav Pediatr."},{"issue":"4","key":"346_CR66","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.eurpsy.2014.12.002","volume":"30","author":"P Asherson","year":"2015","unstructured":"Asherson P, Stes S, Nilsson Markhed M, et al. The effects of atomoxetine on emotional control in adults with ADHD: an integrated analysis of multicenter studies. Eur Psychiatry. 2015;30(4):511\u201320.","journal-title":"Eur Psychiatry."},{"issue":"5","key":"346_CR67","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3810\/pgm.2010.09.2200","volume":"122","author":"TE Brown","year":"2010","unstructured":"Brown TE, Landgraf JM. Improvements in executive function correlate with enhanced performance and functioning and health-related quality of life: evidence from 2 large, double-blind, randomized, placebo-controlled trials in ADHD. Postgrad Med. 2010;122(5):42\u201351.","journal-title":"Postgrad Med."},{"issue":"2","key":"346_CR68","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00213-010-1952-2","volume":"212","author":"JC Verster","year":"2010","unstructured":"Verster JC, Bekker EM, Kooij JJ, et al. Methylphenidate significantly improves declarative memory functioning of adults with ADHD. Psychopharmacology (Berl). 2010;212(2):277\u201381.","journal-title":"Psychopharmacology (Berl)."},{"issue":"8","key":"346_CR69","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.eurpsy.2015.09.005","volume":"30","author":"E Sobanski","year":"2015","unstructured":"Sobanski E, Lepp\u00e4m\u00e4ki S, Bushe C, et al. Patterns of long-term and short-term responses in adult patients with attention-deficit\/hyperactivity disorder in a completer cohort of 12\u00a0weeks or more with atomoxetine. Eur Psychiatry. 2015;30(8):1011\u201320.","journal-title":"Eur Psychiatry."},{"issue":"5","key":"346_CR70","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hup.470070502","volume":"7","author":"ER Volkerts","year":"1992","unstructured":"Volkerts ER, van Laar MW, van Willigenburg APP, et al. A comparative study of on-the-road and stimulated driving performance after nocturnal treatment with lormetazepam 1\u00a0mg and oxazepam 50\u00a0mg. Hum Psychopharmacol. 1992;7(5):297\u2013309.","journal-title":"Hum Psychopharmacol."}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-016-0346-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-016-0346-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-016-0346-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T12:06:46Z","timestamp":1656590806000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-016-0346-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,25]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["346"],"URL":"https:\/\/doi.org\/10.1007\/s40263-016-0346-3","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,25]]}}}